Sewoon Medical Inkomsten in het verleden
Verleden criteriumcontroles 4/6
Sewoon Medical's earnings have been declining at an average annual rate of -1.3%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been declining at an average rate of 0.09% per year. Sewoon Medical's return on equity is 10.3%, and it has net margins of 21.8%.
Belangrijke informatie
-1.3%
Groei van de winst
-1.3%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 22.7% |
| Inkomstengroei | -0.09% |
| Rendement op eigen vermogen | 10.3% |
| Nettomarge | 21.8% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Does Sewoon Medical (KOSDAQ:100700) Deserve A Spot On Your Watchlist?
May 13
Is Sewoon Medical (KOSDAQ:100700) Likely To Turn Things Around?
Mar 08How Does Sewoon Medical Co., Ltd (KOSDAQ:100700) Stand Up To These Simple Dividend Safety Checks?
Feb 18What Type Of Shareholders Own The Most Number of Sewoon Medical Co., Ltd (KOSDAQ:100700) Shares?
Jan 31Sewoon Medical Co., Ltd's (KOSDAQ:100700) Stock Is Going Strong: Have Financials A Role To Play?
Jan 12Sewoon Medical (KOSDAQ:100700) Shareholders Have Enjoyed A 93% Share Price Gain
Dec 24
Will Sewoon Medical (KOSDAQ:100700) Multiply In Value Going Forward?
Dec 06Opbrengsten en kosten
Hoe Sewoon Medical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 64,875 | 14,145 | 9,571 | 503 |
| 31 Mar 24 | 67,205 | 14,849 | 9,405 | 482 |
| 31 Dec 23 | 68,247 | 14,957 | 9,330 | 468 |
| 30 Sep 23 | 67,251 | 14,233 | 9,091 | 476 |
| 30 Jun 23 | 64,694 | 12,722 | 9,009 | 486 |
| 31 Mar 23 | 62,512 | 11,771 | 8,877 | 508 |
| 31 Dec 22 | 60,116 | 10,406 | 8,734 | 505 |
| 30 Sep 22 | 60,272 | 10,759 | 8,515 | 485 |
| 30 Jun 22 | 61,114 | 11,152 | 8,446 | 472 |
| 31 Mar 22 | 61,649 | 11,339 | 8,522 | 417 |
| 31 Dec 21 | 62,579 | 12,282 | 8,466 | 428 |
| 30 Sep 21 | 61,452 | 10,707 | 8,898 | 414 |
| 30 Jun 21 | 60,664 | 10,385 | 8,912 | 387 |
| 31 Mar 21 | 62,908 | 10,170 | 8,783 | 349 |
| 31 Dec 20 | 63,729 | 10,209 | 8,842 | 321 |
| 30 Sep 20 | 65,540 | 10,974 | 8,628 | 326 |
| 30 Jun 20 | 66,592 | 11,870 | 8,835 | 321 |
| 31 Mar 20 | 66,379 | 14,442 | 9,097 | 336 |
| 31 Dec 19 | 66,869 | 13,973 | 9,697 | 340 |
| 30 Sep 19 | 65,599 | 17,721 | 9,295 | 318 |
| 30 Jun 19 | 64,421 | 16,702 | 9,524 | 302 |
| 31 Mar 19 | 63,368 | 14,082 | 9,491 | 276 |
| 31 Dec 18 | 63,121 | 13,808 | 9,705 | 246 |
| 30 Sep 18 | 62,587 | 10,763 | 10,609 | 304 |
| 30 Jun 18 | 63,356 | 10,397 | 10,768 | 298 |
| 31 Mar 18 | 61,447 | 9,556 | 10,684 | 273 |
| 31 Dec 17 | 61,230 | 9,177 | 10,419 | 269 |
| 30 Sep 17 | 59,574 | 7,809 | 10,294 | 209 |
| 30 Jun 17 | 58,071 | 7,565 | 9,978 | 227 |
| 31 Mar 17 | 57,757 | 8,694 | 9,917 | 233 |
| 31 Dec 16 | 56,620 | 8,349 | 9,555 | 223 |
| 30 Sep 16 | 57,619 | 9,052 | 9,364 | 215 |
| 30 Jun 16 | 56,517 | 3,968 | 9,667 | 366 |
| 31 Mar 16 | 56,058 | 3,321 | 9,705 | 357 |
| 31 Dec 15 | 55,867 | 3,064 | 9,692 | 381 |
| 30 Sep 15 | 54,944 | 1,345 | 9,850 | 424 |
| 30 Jun 15 | 55,092 | 6,456 | 9,043 | 209 |
| 31 Mar 15 | 53,647 | 5,162 | 8,511 | 191 |
| 31 Dec 14 | 52,871 | 5,992 | 8,040 | 244 |
| 30 Sep 14 | 52,589 | 8,145 | 7,367 | 269 |
| 30 Jun 14 | 52,100 | 7,964 | 6,994 | 352 |
| 31 Mar 14 | 52,604 | 9,192 | 7,062 | 397 |
| 31 Dec 13 | 51,423 | 8,519 | 7,104 | 322 |
Kwaliteitswinsten: A100700 has high quality earnings.
Groeiende winstmarge: A100700's current net profit margins (21.8%) are higher than last year (19.7%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: A100700's earnings have declined by 1.3% per year over the past 5 years.
Versnelling van de groei: A100700's earnings growth over the past year (11.2%) exceeds its 5-year average (-1.3% per year).
Winst versus industrie: A100700 earnings growth over the past year (11.2%) exceeded the Medical Equipment industry 4%.
Rendement op eigen vermogen
Hoge ROE: A100700's Return on Equity (10.3%) is considered low.